Quick Facts Field Details Active Ingredient Alemtuzumab Drug Category Rare / Orphan Diseases Primary Use Highly active relapsing MS (anti-CD52 biologic) Availability Available in Turkey ✓ Introduction Alemtuzumab is a...
Quick Facts Field Details Active Ingredient Ponesimod Drug Category Rare / Orphan Diseases Primary Use Relapsing MS (S1P1 receptor modulator) Availability Available in Turkey ✓ Introduction Ponesimod is a Rare...
Quick Facts Field Details Active Ingredient Ozanimod Drug Category Rare / Orphan Diseases Primary Use Relapsing MS, ulcerative colitis (S1P modulator) Availability Available in Turkey ✓ Introduction Ozanimod is a...
Quick Facts Field Details Active Ingredient Natalizumab Drug Category Rare / Orphan Diseases Primary Use Relapsing multiple sclerosis, Crohn’s (anti-alpha4 integrin) Availability Available in Turkey ✓ Introduction Natalizumab is a...
Quick Facts Field Details Active Ingredient Siponimod Drug Category Rare / Orphan Diseases Primary Use Secondary progressive multiple sclerosis (S1P modulator) Availability Available in Turkey ✓ Introduction Siponimod is a...
Quick Facts Field Details Active Ingredient Ofatumumab Drug Category Rare / Orphan Diseases Primary Use Relapsing multiple sclerosis (anti-CD20 SC injection) Availability Available in Turkey ✓ Introduction Ofatumumab is a...
Quick Facts Field Details Active Ingredient Ocrelizumab Drug Category Rare / Orphan Diseases Primary Use Relapsing and progressive multiple sclerosis (anti-CD20) Availability Available in Turkey ✓ Introduction Ocrelizumab is a...
Quick Facts Field Details Active Ingredient Ublituximab Drug Category Rare / Orphan Diseases Primary Use Relapsing multiple sclerosis (anti-CD20) Availability Available in Turkey ✓ Introduction Ublituximab is a Rare /...
Quick Facts Field Details Active Ingredient Satralizumab Drug Category Rare / Orphan Diseases Primary Use Neuromyelitis optica spectrum disorder — NMOSD (anti-IL-6R) Availability Available in Turkey ✓ Introduction Satralizumab is...
Quick Facts Field Details Active Ingredient Inebilizumab Drug Category Rare / Orphan Diseases Primary Use Neuromyelitis optica spectrum disorder — NMOSD (anti-CD19) Availability Available in Turkey ✓ Introduction Inebilizumab is...